Trivers KF, Fink AK, Partridge AH, Oktay K, Ginsburg ES, Li C, et al. Estimates of young breast cancer survivors at risk for infertility in the U.S. Oncologist. 2014;19:814–22. https://doi.org/10.1634/theoncologist.2014-0016.
Article PubMed PubMed Central Google Scholar
Brunner HI, Bishnoi A, Barron AC, Houk LJ, Ware A, Farhey Y, et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus. 2006;15:198–206. https://doi.org/10.1191/0961203306lu2291oa.
Article CAS PubMed Google Scholar
Touma Z, Gladman DD, Urowitz MB, Beyene J, Uleryk EM, Shah PS. Mycophenolate mofetil for induction treatment of lupus nephritis: A systematic review and metaanalysis. J Rheumatol. 2011;38:69–78. https://doi.org/10.3899/jrheum.100130.
Article CAS PubMed Google Scholar
Danis RB, Pereira N, Elias RT. Random start ovarian stimulation for oocyte or embryo cryopreservation in women desiring fertility preservation prior to gonadotoxic cancer therapy. Curr Pharm Biotechnol. 2017;18:609–13. https://doi.org/10.2174/1389201018666170808122531.
Article CAS PubMed Google Scholar
Yu KD, Huang S, Zhang JX, Liu GY, Shao ZM. Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: A systematic review and meta-analysis. BMC Cancer. 2013;13:240. https://doi.org/10.1186/1471-2407-13-240.
Article CAS PubMed PubMed Central Google Scholar
Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2016;2:322–9. https://doi.org/10.1001/jamaoncol.2015.3856.
Article PubMed PubMed Central Google Scholar
Arecco L, Blondeaux E, Bruzzone M, Ceppi M, Latocca MM, Marrocco C, et al. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: A systematic review and meta-analysis. Hum Reprod. 2022;37:954–68. https://doi.org/10.1093/humrep/deac035.
Article CAS PubMed PubMed Central Google Scholar
Rodgers RJ, Reid GD, Koch J, Deans R, Ledger WL, Friedlander M, et al. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: A systematic review. Hum Reprod. 2017;32:1033–45. https://doi.org/10.1093/humrep/dex027.
Article CAS PubMed Google Scholar
Pereira N, Hancock K, Cordeiro CN, Lekovich JP, Schattman GL, Rosenwaks Z. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†. Gynecol Endocrinol. 2016;32:823–6. https://doi.org/10.1080/09513590.2016.1177013.
Article CAS PubMed Google Scholar
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: A guideline. Fertil Steril. 2013;99:37–43. https://doi.org/10.1016/j.fertnstert.2012.09.028
Peters ITA, van Zwet EW, Smit VTHBM, Liefers GJ, Kuppen PJK, Hilders CGJM, et al. Prevalence and risk factors of ovarian metastases in breast cancer patients < 41 years of age in the Netherlands: A nationwide retrospective cohort study. PLoS One. 2017;12:e0168277. https://doi.org/10.1371/journal.pone.0168277.
Article CAS PubMed PubMed Central Google Scholar
Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58–64. https://doi.org/10.1016/j.ygyno.2005.06.065.
Article CAS PubMed Google Scholar
Luyckx V, Durant JF, Camboni A, Gilliaux S, Amorim CA, Van Langendonckt A, et al. Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study. J Assist Reprod Genet. 2013;30:1289–99. https://doi.org/10.1007/s10815-013-0065-3.
Article CAS PubMed PubMed Central Google Scholar
Dolmans MM, von Wolff M, Poirot C, Diaz-Garcia C, Cacciottola L, Boissel N, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: A review of five leading European centers. Fertil Steril. 2021;115:1102–15. https://doi.org/10.1016/j.fertnstert.2021.03.008.
Article CAS PubMed Google Scholar
Vitek WS, Shayne M, Hoeger K, Han Y, Messing S, Fung C. Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: A systematic review and meta-analysis. Fertil Steril. 2014;102:808-815.e1. https://doi.org/10.1016/j.fertnstert.2014.06.003.
Article CAS PubMed Google Scholar
Munhoz RR, Pereira AAL, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al. Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: A systematic review and meta-analysis. JAMA Oncol. 2016;2:65–73. https://doi.org/10.1001/jamaoncol.2015.3251.
Article PubMed PubMed Central Google Scholar
Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient-level data. J Clin Oncol. 2018;36:1981–90. https://doi.org/10.1200/JCO.2018.78.0858.
Article CAS PubMed PubMed Central Google Scholar
Yuan Y, Zhang C, Lei X, Ren T, Chen H, Zhao Q. Gonadotropin-releasing hormone agonists during gonadal chemotherapy for the effect on pregnancy outcome and ovarian function in premenopausal patients with breast cancer: A systematic review and meta-analysis. Breast Care (Basel). 2023;18:270–8. https://doi.org/10.1159/000528028.
Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36:1994–2001. https://doi.org/10.1200/JCO.2018.78.1914.
Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†. Ann Oncol. 2020;31:1664–78. https://doi.org/10.1016/j.annonc.2020.09.006.
Article CAS PubMed Google Scholar
ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, D’Angelo A, de Sousa C, Lopes SM, et al. [ESHRE guideline]. ESHRE guideline: Female fertility preservation. Hum Reprod Open. 2020;2020:hoaa052. https://doi.org/10.1093/hropen/hoaa052.
Wang Y, Tesch ME, Lim C, Xu YH, Lee S, Perdizet K, et al. Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation. Breast Cancer Res Treat. 2022;195:201–8. https://doi.org/10.1007/s10549-022-06650-z.
Salama M, Lambertini M, Christianson MS, Jayasinghe Y, Anazodo A, De Vos M, et al. Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & II. J Assist Reprod Genet. 2022;39:505–16. https://doi.org/10.1007/s10815-022-02394-3.
Article PubMed PubMed Central Google Scholar
Blondeaux E, Massarotti C, Fontana V, Poggio F, Arecco L, Fregatti P, et al. The PREgnancy and FERtility (PREFER) study investigating the need for ovarian function and/or fertility preservation strategies in premenopausal women with early breast cancer. Front Oncol. 2021;11:690320. https://doi.org/10.3389/fonc.2021.690320.
Article CAS PubMed PubMed Central Google Scholar
Duraes M, Rathat G, Bringer-Deutsch S, Ranisavljevic N, Brouillet S, Defez-Fougeron C, et al. Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study. Breast. 2022;64:121–6. https://doi.org/10.1016/j.breast.2022.05.006.
Article PubMed PubMed Central Google Scholar
Swain M, Miller M, Cannella C, Daviskiba S. Disparities in fertility preservation among patients diagnosed with female breast cancer. J Assist Reprod Genet. 2023;40:2843–9. https://doi.org/10.1007/s10815-023-02968-9.
Sauerbrun-Cutler MT, Pandya S, Recabo O, Raker C, Clark MA, Robison K. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care. J Assist Reprod Genet. 2023;40:2003–11. https://doi.org/10.1007/s10815-023-02850-8.
Comments (0)